Turn Therapeutics (TTRX) Other Working Capital Changes (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Other Working Capital Changes of $123738.0 for Q1 2026, down 56.91% year-over-year from $287141.0 in Q1 2025, and up 281.21% quarter-over-quarter from -$68283.0 in Q4 2025.
Powered by 
Analysis
Turn Therapeutics (TTRX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Turn Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $123738.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 56.91% year-over-year to $123738.0; the TTM figure through Mar 2026 stood at $561254.0 (changed N/A YoY), while the FY2025 annual figure was -$105025.0, down 151.36% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $123738.0, up from -$68283.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $287141.0 in Q1 2025, with the low at -$68283.0 in Q4 2025.
- The 3-year median for Other Working Capital Changes is $171198.0 (2024), against an average of $140313.5.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes sank 131.23% in 2025, then sank 56.91% in 2026.
- Turn Therapeutics' Other Working Capital Changes stood at $218658.0 in 2024, then tumbled by 131.23% to -$68283.0 in 2025, then soared by 281.21% to $123738.0 in 2026.
- Business Quant data shows TTRX's Other Working Capital Changes at $123738.0 in Q1 2026, -$68283.0 in Q4 2025, and $287141.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Turn Therapeutics | 302.05 Mn | 302.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -104,355.00 |
| Jun 30, 2026 | -104,355.00 |
| Mar 31, 2026 | 123,738.00 |
| Mar 31, 2026 | 123,738.00 |
| Dec 31, 2025 | -68,283.00 |
| Dec 31, 2025 | -68,283.00 |
| Sep 30, 2025 | -15,435.00 |
| Sep 30, 2025 | -15,435.00 |
| Jun 30, 2025 | -308,448.00 |
| Jun 30, 2025 | -308,448.00 |
| Mar 31, 2025 | 287,141.00 |
| Mar 31, 2025 | 287,141.00 |
| Dec 31, 2024 | 218,658.00 |
| Dec 31, 2024 | 218,658.00 |